PUBLIC COMPANY
save$INMBInmune Bio, Inc.
$INMBBoca Raton, FL, USupdated 21d ago
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Phase 11Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML
- phase2A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation
- phase2An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
- phase2Study of INKmune in Patients With mCRPC (CaRe Prostate)
- phase2Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation
- phase1A Biomarker-directed Study of XPro1595 in Patients With Alzheimer's
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed just now
Found something off?
comments(0)
5-min edit window · permanent after that